Pharma & Healthcare
Oncology Adjuvants - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 548686
- Pages: 138
- Figures: 251
- Views: 1
Oncology adjuvants are substances or therapies used in combination with primary cancer treatments, such as surgery, chemotherapy, or radiation therapy, to enhance their efficacy or reduce the risk of cancer recurrence.
The global market for Oncology Adjuvants was estimated to be worth US$ 469.7 million in 2023 and is forecast to a readjusted size of US$ 599 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030
The market for oncology adjuvants is driven by the need for improved cancer treatment outcomes and the demand for personalized and targeted cancer therapies. The market's growth is also influenced by ongoing research in cancer immunotherapy and the development of novel adjuvant therapies.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oncology Adjuvants, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oncology Adjuvants by region & country, by Type, and by Application.
The Oncology Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Adjuvants.
Market Segmentation
By Company
Eli Lilly
Amgen
BMS
Biogen
Sanofi
AstraZeneca
Pfizer
Hengrui Medicine
Hisun Pharmaceutical
Yibai Pharmaceutical
SL Pharmaceutical
Zhendong Pharmaceutical
Main Luck Pharmaceuticals
Sanjiu Medical
Livzon Pharmaceutical
Segment by Type:
Radiotherapy
Chemotherapy
Immunotherapy
Hormone therapy
Targeted therapy
Segment by Application
Cancer Research Institutes
Cancer Hospitals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oncology Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Oncology Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Oncology Adjuvants in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Oncology Adjuvants was estimated to be worth US$ 469.7 million in 2023 and is forecast to a readjusted size of US$ 599 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030
The market for oncology adjuvants is driven by the need for improved cancer treatment outcomes and the demand for personalized and targeted cancer therapies. The market's growth is also influenced by ongoing research in cancer immunotherapy and the development of novel adjuvant therapies.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oncology Adjuvants, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oncology Adjuvants by region & country, by Type, and by Application.
The Oncology Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Adjuvants.
Market Segmentation
By Company
Eli Lilly
Amgen
BMS
Biogen
Sanofi
AstraZeneca
Pfizer
Hengrui Medicine
Hisun Pharmaceutical
Yibai Pharmaceutical
SL Pharmaceutical
Zhendong Pharmaceutical
Main Luck Pharmaceuticals
Sanjiu Medical
Livzon Pharmaceutical
Segment by Type:
Radiotherapy
Chemotherapy
Immunotherapy
Hormone therapy
Targeted therapy
Segment by Application
Cancer Research Institutes
Cancer Hospitals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oncology Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Oncology Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Oncology Adjuvants in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Oncology Adjuvants Product Introduction
1.2 Global Oncology Adjuvants Market Size Forecast
1.2.1 Global Oncology Adjuvants Sales Value (2019-2030)
1.2.2 Global Oncology Adjuvants Sales Volume (2019-2030)
1.2.3 Global Oncology Adjuvants Sales Price (2019-2030)
1.3 Oncology Adjuvants Market Trends & Drivers
1.3.1 Oncology Adjuvants Industry Trends
1.3.2 Oncology Adjuvants Market Drivers & Opportunity
1.3.3 Oncology Adjuvants Market Challenges
1.3.4 Oncology Adjuvants Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oncology Adjuvants Players Revenue Ranking (2023)
2.2 Global Oncology Adjuvants Revenue by Company (2019-2024)
2.3 Global Oncology Adjuvants Players Sales Volume Ranking (2023)
2.4 Global Oncology Adjuvants Sales Volume by Company Players (2019-2024)
2.5 Global Oncology Adjuvants Average Price by Company (2019-2024)
2.6 Key Manufacturers Oncology Adjuvants Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Oncology Adjuvants Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Oncology Adjuvants
2.9 Oncology Adjuvants Market Competitive Analysis
2.9.1 Oncology Adjuvants Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Oncology Adjuvants Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Adjuvants as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Radiotherapy
3.1.2 Chemotherapy
3.1.3 Immunotherapy
3.1.4 Hormone therapy
3.1.5 Targeted therapy
3.2 Global Oncology Adjuvants Sales Value by Type
3.2.1 Global Oncology Adjuvants Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Oncology Adjuvants Sales Value, by Type (2019-2030)
3.2.3 Global Oncology Adjuvants Sales Value, by Type (%) (2019-2030)
3.3 Global Oncology Adjuvants Sales Volume by Type
3.3.1 Global Oncology Adjuvants Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Oncology Adjuvants Sales Volume, by Type (2019-2030)
3.3.3 Global Oncology Adjuvants Sales Volume, by Type (%) (2019-2030)
3.4 Global Oncology Adjuvants Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cancer Research Institutes
4.1.2 Cancer Hospitals
4.2 Global Oncology Adjuvants Sales Value by Application
4.2.1 Global Oncology Adjuvants Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Oncology Adjuvants Sales Value, by Application (2019-2030)
4.2.3 Global Oncology Adjuvants Sales Value, by Application (%) (2019-2030)
4.3 Global Oncology Adjuvants Sales Volume by Application
4.3.1 Global Oncology Adjuvants Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Oncology Adjuvants Sales Volume, by Application (2019-2030)
4.3.3 Global Oncology Adjuvants Sales Volume, by Application (%) (2019-2030)
4.4 Global Oncology Adjuvants Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Oncology Adjuvants Sales Value by Region
5.1.1 Global Oncology Adjuvants Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Oncology Adjuvants Sales Value by Region (2019-2024)
5.1.3 Global Oncology Adjuvants Sales Value by Region (2025-2030)
5.1.4 Global Oncology Adjuvants Sales Value by Region (%), (2019-2030)
5.2 Global Oncology Adjuvants Sales Volume by Region
5.2.1 Global Oncology Adjuvants Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Oncology Adjuvants Sales Volume by Region (2019-2024)
5.2.3 Global Oncology Adjuvants Sales Volume by Region (2025-2030)
5.2.4 Global Oncology Adjuvants Sales Volume by Region (%), (2019-2030)
5.3 Global Oncology Adjuvants Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Oncology Adjuvants Sales Value, 2019-2030
5.4.2 North America Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Oncology Adjuvants Sales Value, 2019-2030
5.5.2 Europe Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Oncology Adjuvants Sales Value, 2019-2030
5.6.2 Asia Pacific Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Oncology Adjuvants Sales Value, 2019-2030
5.7.2 South America Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Oncology Adjuvants Sales Value, 2019-2030
5.8.2 Middle East & Africa Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oncology Adjuvants Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Oncology Adjuvants Sales Value
6.2.1 Key Countries/Regions Oncology Adjuvants Sales Value, 2019-2030
6.2.2 Key Countries/Regions Oncology Adjuvants Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Oncology Adjuvants Sales Value, 2019-2030
6.3.2 United States Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Oncology Adjuvants Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Oncology Adjuvants Sales Value, 2019-2030
6.4.2 Europe Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Oncology Adjuvants Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Oncology Adjuvants Sales Value, 2019-2030
6.5.2 China Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
6.5.3 China Oncology Adjuvants Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Oncology Adjuvants Sales Value, 2019-2030
6.6.2 Japan Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Oncology Adjuvants Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Oncology Adjuvants Sales Value, 2019-2030
6.7.2 South Korea Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Oncology Adjuvants Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Oncology Adjuvants Sales Value, 2019-2030
6.8.2 Southeast Asia Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Oncology Adjuvants Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Oncology Adjuvants Sales Value, 2019-2030
6.9.2 India Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
6.9.3 India Oncology Adjuvants Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Information
7.1.2 Eli Lilly Introduction and Business Overview
7.1.3 Eli Lilly Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Eli Lilly Oncology Adjuvants Product Offerings
7.1.5 Eli Lilly Recent Development
7.2 Amgen
7.2.1 Amgen Company Information
7.2.2 Amgen Introduction and Business Overview
7.2.3 Amgen Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Amgen Oncology Adjuvants Product Offerings
7.2.5 Amgen Recent Development
7.3 BMS
7.3.1 BMS Company Information
7.3.2 BMS Introduction and Business Overview
7.3.3 BMS Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.3.4 BMS Oncology Adjuvants Product Offerings
7.3.5 BMS Recent Development
7.4 Biogen
7.4.1 Biogen Company Information
7.4.2 Biogen Introduction and Business Overview
7.4.3 Biogen Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Biogen Oncology Adjuvants Product Offerings
7.4.5 Biogen Recent Development
7.5 Sanofi
7.5.1 Sanofi Company Information
7.5.2 Sanofi Introduction and Business Overview
7.5.3 Sanofi Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sanofi Oncology Adjuvants Product Offerings
7.5.5 Sanofi Recent Development
7.6 AstraZeneca
7.6.1 AstraZeneca Company Information
7.6.2 AstraZeneca Introduction and Business Overview
7.6.3 AstraZeneca Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.6.4 AstraZeneca Oncology Adjuvants Product Offerings
7.6.5 AstraZeneca Recent Development
7.7 Pfizer
7.7.1 Pfizer Company Information
7.7.2 Pfizer Introduction and Business Overview
7.7.3 Pfizer Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Pfizer Oncology Adjuvants Product Offerings
7.7.5 Pfizer Recent Development
7.8 Hengrui Medicine
7.8.1 Hengrui Medicine Company Information
7.8.2 Hengrui Medicine Introduction and Business Overview
7.8.3 Hengrui Medicine Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Hengrui Medicine Oncology Adjuvants Product Offerings
7.8.5 Hengrui Medicine Recent Development
7.9 Hisun Pharmaceutical
7.9.1 Hisun Pharmaceutical Company Information
7.9.2 Hisun Pharmaceutical Introduction and Business Overview
7.9.3 Hisun Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Hisun Pharmaceutical Oncology Adjuvants Product Offerings
7.9.5 Hisun Pharmaceutical Recent Development
7.10 Yibai Pharmaceutical
7.10.1 Yibai Pharmaceutical Company Information
7.10.2 Yibai Pharmaceutical Introduction and Business Overview
7.10.3 Yibai Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Yibai Pharmaceutical Oncology Adjuvants Product Offerings
7.10.5 Yibai Pharmaceutical Recent Development
7.11 SL Pharmaceutical
7.11.1 SL Pharmaceutical Company Information
7.11.2 SL Pharmaceutical Introduction and Business Overview
7.11.3 SL Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.11.4 SL Pharmaceutical Oncology Adjuvants Product Offerings
7.11.5 SL Pharmaceutical Recent Development
7.12 Zhendong Pharmaceutical
7.12.1 Zhendong Pharmaceutical Company Information
7.12.2 Zhendong Pharmaceutical Introduction and Business Overview
7.12.3 Zhendong Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Zhendong Pharmaceutical Oncology Adjuvants Product Offerings
7.12.5 Zhendong Pharmaceutical Recent Development
7.13 Main Luck Pharmaceuticals
7.13.1 Main Luck Pharmaceuticals Company Information
7.13.2 Main Luck Pharmaceuticals Introduction and Business Overview
7.13.3 Main Luck Pharmaceuticals Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Main Luck Pharmaceuticals Oncology Adjuvants Product Offerings
7.13.5 Main Luck Pharmaceuticals Recent Development
7.14 Sanjiu Medical
7.14.1 Sanjiu Medical Company Information
7.14.2 Sanjiu Medical Introduction and Business Overview
7.14.3 Sanjiu Medical Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Sanjiu Medical Oncology Adjuvants Product Offerings
7.14.5 Sanjiu Medical Recent Development
7.15 Livzon Pharmaceutical
7.15.1 Livzon Pharmaceutical Company Information
7.15.2 Livzon Pharmaceutical Introduction and Business Overview
7.15.3 Livzon Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Livzon Pharmaceutical Oncology Adjuvants Product Offerings
7.15.5 Livzon Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Oncology Adjuvants Industrial Chain
8.2 Oncology Adjuvants Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oncology Adjuvants Sales Model
8.5.2 Sales Channel
8.5.3 Oncology Adjuvants Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Oncology Adjuvants Product Introduction
1.2 Global Oncology Adjuvants Market Size Forecast
1.2.1 Global Oncology Adjuvants Sales Value (2019-2030)
1.2.2 Global Oncology Adjuvants Sales Volume (2019-2030)
1.2.3 Global Oncology Adjuvants Sales Price (2019-2030)
1.3 Oncology Adjuvants Market Trends & Drivers
1.3.1 Oncology Adjuvants Industry Trends
1.3.2 Oncology Adjuvants Market Drivers & Opportunity
1.3.3 Oncology Adjuvants Market Challenges
1.3.4 Oncology Adjuvants Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oncology Adjuvants Players Revenue Ranking (2023)
2.2 Global Oncology Adjuvants Revenue by Company (2019-2024)
2.3 Global Oncology Adjuvants Players Sales Volume Ranking (2023)
2.4 Global Oncology Adjuvants Sales Volume by Company Players (2019-2024)
2.5 Global Oncology Adjuvants Average Price by Company (2019-2024)
2.6 Key Manufacturers Oncology Adjuvants Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Oncology Adjuvants Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Oncology Adjuvants
2.9 Oncology Adjuvants Market Competitive Analysis
2.9.1 Oncology Adjuvants Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Oncology Adjuvants Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Adjuvants as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Radiotherapy
3.1.2 Chemotherapy
3.1.3 Immunotherapy
3.1.4 Hormone therapy
3.1.5 Targeted therapy
3.2 Global Oncology Adjuvants Sales Value by Type
3.2.1 Global Oncology Adjuvants Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Oncology Adjuvants Sales Value, by Type (2019-2030)
3.2.3 Global Oncology Adjuvants Sales Value, by Type (%) (2019-2030)
3.3 Global Oncology Adjuvants Sales Volume by Type
3.3.1 Global Oncology Adjuvants Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Oncology Adjuvants Sales Volume, by Type (2019-2030)
3.3.3 Global Oncology Adjuvants Sales Volume, by Type (%) (2019-2030)
3.4 Global Oncology Adjuvants Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cancer Research Institutes
4.1.2 Cancer Hospitals
4.2 Global Oncology Adjuvants Sales Value by Application
4.2.1 Global Oncology Adjuvants Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Oncology Adjuvants Sales Value, by Application (2019-2030)
4.2.3 Global Oncology Adjuvants Sales Value, by Application (%) (2019-2030)
4.3 Global Oncology Adjuvants Sales Volume by Application
4.3.1 Global Oncology Adjuvants Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Oncology Adjuvants Sales Volume, by Application (2019-2030)
4.3.3 Global Oncology Adjuvants Sales Volume, by Application (%) (2019-2030)
4.4 Global Oncology Adjuvants Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Oncology Adjuvants Sales Value by Region
5.1.1 Global Oncology Adjuvants Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Oncology Adjuvants Sales Value by Region (2019-2024)
5.1.3 Global Oncology Adjuvants Sales Value by Region (2025-2030)
5.1.4 Global Oncology Adjuvants Sales Value by Region (%), (2019-2030)
5.2 Global Oncology Adjuvants Sales Volume by Region
5.2.1 Global Oncology Adjuvants Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Oncology Adjuvants Sales Volume by Region (2019-2024)
5.2.3 Global Oncology Adjuvants Sales Volume by Region (2025-2030)
5.2.4 Global Oncology Adjuvants Sales Volume by Region (%), (2019-2030)
5.3 Global Oncology Adjuvants Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Oncology Adjuvants Sales Value, 2019-2030
5.4.2 North America Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Oncology Adjuvants Sales Value, 2019-2030
5.5.2 Europe Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Oncology Adjuvants Sales Value, 2019-2030
5.6.2 Asia Pacific Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Oncology Adjuvants Sales Value, 2019-2030
5.7.2 South America Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Oncology Adjuvants Sales Value, 2019-2030
5.8.2 Middle East & Africa Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oncology Adjuvants Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Oncology Adjuvants Sales Value
6.2.1 Key Countries/Regions Oncology Adjuvants Sales Value, 2019-2030
6.2.2 Key Countries/Regions Oncology Adjuvants Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Oncology Adjuvants Sales Value, 2019-2030
6.3.2 United States Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Oncology Adjuvants Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Oncology Adjuvants Sales Value, 2019-2030
6.4.2 Europe Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Oncology Adjuvants Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Oncology Adjuvants Sales Value, 2019-2030
6.5.2 China Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
6.5.3 China Oncology Adjuvants Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Oncology Adjuvants Sales Value, 2019-2030
6.6.2 Japan Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Oncology Adjuvants Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Oncology Adjuvants Sales Value, 2019-2030
6.7.2 South Korea Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Oncology Adjuvants Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Oncology Adjuvants Sales Value, 2019-2030
6.8.2 Southeast Asia Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Oncology Adjuvants Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Oncology Adjuvants Sales Value, 2019-2030
6.9.2 India Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
6.9.3 India Oncology Adjuvants Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Information
7.1.2 Eli Lilly Introduction and Business Overview
7.1.3 Eli Lilly Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Eli Lilly Oncology Adjuvants Product Offerings
7.1.5 Eli Lilly Recent Development
7.2 Amgen
7.2.1 Amgen Company Information
7.2.2 Amgen Introduction and Business Overview
7.2.3 Amgen Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Amgen Oncology Adjuvants Product Offerings
7.2.5 Amgen Recent Development
7.3 BMS
7.3.1 BMS Company Information
7.3.2 BMS Introduction and Business Overview
7.3.3 BMS Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.3.4 BMS Oncology Adjuvants Product Offerings
7.3.5 BMS Recent Development
7.4 Biogen
7.4.1 Biogen Company Information
7.4.2 Biogen Introduction and Business Overview
7.4.3 Biogen Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Biogen Oncology Adjuvants Product Offerings
7.4.5 Biogen Recent Development
7.5 Sanofi
7.5.1 Sanofi Company Information
7.5.2 Sanofi Introduction and Business Overview
7.5.3 Sanofi Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sanofi Oncology Adjuvants Product Offerings
7.5.5 Sanofi Recent Development
7.6 AstraZeneca
7.6.1 AstraZeneca Company Information
7.6.2 AstraZeneca Introduction and Business Overview
7.6.3 AstraZeneca Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.6.4 AstraZeneca Oncology Adjuvants Product Offerings
7.6.5 AstraZeneca Recent Development
7.7 Pfizer
7.7.1 Pfizer Company Information
7.7.2 Pfizer Introduction and Business Overview
7.7.3 Pfizer Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Pfizer Oncology Adjuvants Product Offerings
7.7.5 Pfizer Recent Development
7.8 Hengrui Medicine
7.8.1 Hengrui Medicine Company Information
7.8.2 Hengrui Medicine Introduction and Business Overview
7.8.3 Hengrui Medicine Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Hengrui Medicine Oncology Adjuvants Product Offerings
7.8.5 Hengrui Medicine Recent Development
7.9 Hisun Pharmaceutical
7.9.1 Hisun Pharmaceutical Company Information
7.9.2 Hisun Pharmaceutical Introduction and Business Overview
7.9.3 Hisun Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Hisun Pharmaceutical Oncology Adjuvants Product Offerings
7.9.5 Hisun Pharmaceutical Recent Development
7.10 Yibai Pharmaceutical
7.10.1 Yibai Pharmaceutical Company Information
7.10.2 Yibai Pharmaceutical Introduction and Business Overview
7.10.3 Yibai Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Yibai Pharmaceutical Oncology Adjuvants Product Offerings
7.10.5 Yibai Pharmaceutical Recent Development
7.11 SL Pharmaceutical
7.11.1 SL Pharmaceutical Company Information
7.11.2 SL Pharmaceutical Introduction and Business Overview
7.11.3 SL Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.11.4 SL Pharmaceutical Oncology Adjuvants Product Offerings
7.11.5 SL Pharmaceutical Recent Development
7.12 Zhendong Pharmaceutical
7.12.1 Zhendong Pharmaceutical Company Information
7.12.2 Zhendong Pharmaceutical Introduction and Business Overview
7.12.3 Zhendong Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Zhendong Pharmaceutical Oncology Adjuvants Product Offerings
7.12.5 Zhendong Pharmaceutical Recent Development
7.13 Main Luck Pharmaceuticals
7.13.1 Main Luck Pharmaceuticals Company Information
7.13.2 Main Luck Pharmaceuticals Introduction and Business Overview
7.13.3 Main Luck Pharmaceuticals Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Main Luck Pharmaceuticals Oncology Adjuvants Product Offerings
7.13.5 Main Luck Pharmaceuticals Recent Development
7.14 Sanjiu Medical
7.14.1 Sanjiu Medical Company Information
7.14.2 Sanjiu Medical Introduction and Business Overview
7.14.3 Sanjiu Medical Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Sanjiu Medical Oncology Adjuvants Product Offerings
7.14.5 Sanjiu Medical Recent Development
7.15 Livzon Pharmaceutical
7.15.1 Livzon Pharmaceutical Company Information
7.15.2 Livzon Pharmaceutical Introduction and Business Overview
7.15.3 Livzon Pharmaceutical Oncology Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Livzon Pharmaceutical Oncology Adjuvants Product Offerings
7.15.5 Livzon Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Oncology Adjuvants Industrial Chain
8.2 Oncology Adjuvants Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oncology Adjuvants Sales Model
8.5.2 Sales Channel
8.5.3 Oncology Adjuvants Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Oncology Adjuvants Market Trends
Table 2. Oncology Adjuvants Market Drivers & Opportunity
Table 3. Oncology Adjuvants Market Challenges
Table 4. Oncology Adjuvants Market Restraints
Table 5. Global Oncology Adjuvants Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Oncology Adjuvants Revenue Market Share by Company (2019-2024)
Table 7. Global Oncology Adjuvants Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Oncology Adjuvants Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Oncology Adjuvants Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Oncology Adjuvants Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Oncology Adjuvants Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Oncology Adjuvants
Table 13. Global Oncology Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Adjuvants as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Oncology Adjuvants Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Oncology Adjuvants Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Oncology Adjuvants Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Oncology Adjuvants Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Oncology Adjuvants Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Oncology Adjuvants Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Oncology Adjuvants Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Oncology Adjuvants Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Oncology Adjuvants Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Oncology Adjuvants Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Oncology Adjuvants Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Oncology Adjuvants Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Oncology Adjuvants Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Oncology Adjuvants Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Oncology Adjuvants Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Oncology Adjuvants Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Oncology Adjuvants Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Oncology Adjuvants Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Oncology Adjuvants Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Oncology Adjuvants Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Oncology Adjuvants Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Oncology Adjuvants Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Oncology Adjuvants Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Oncology Adjuvants Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Oncology Adjuvants Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Oncology Adjuvants Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Oncology Adjuvants Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Oncology Adjuvants Sales Value by Region (2019-2024) & (%)
Table 44. Global Oncology Adjuvants Sales Value by Region (2025-2030) & (%)
Table 45. Global Oncology Adjuvants Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Oncology Adjuvants Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Oncology Adjuvants Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Oncology Adjuvants Sales Volume by Region (2019-2024) & (%)
Table 49. Global Oncology Adjuvants Sales Volume by Region (2025-2030) & (%)
Table 50. Global Oncology Adjuvants Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Oncology Adjuvants Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Oncology Adjuvants Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Oncology Adjuvants Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Oncology Adjuvants Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Oncology Adjuvants Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Oncology Adjuvants Sales Volume, (2025-2030) & (K Units)
Table 57. Eli Lilly Company Information
Table 58. Eli Lilly Introduction and Business Overview
Table 59. Eli Lilly Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Eli Lilly Oncology Adjuvants Product Offerings
Table 61. Eli Lilly Recent Development
Table 62. Amgen Company Information
Table 63. Amgen Introduction and Business Overview
Table 64. Amgen Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Amgen Oncology Adjuvants Product Offerings
Table 66. Amgen Recent Development
Table 67. BMS Company Information
Table 68. BMS Introduction and Business Overview
Table 69. BMS Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. BMS Oncology Adjuvants Product Offerings
Table 71. BMS Recent Development
Table 72. Biogen Company Information
Table 73. Biogen Introduction and Business Overview
Table 74. Biogen Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Biogen Oncology Adjuvants Product Offerings
Table 76. Biogen Recent Development
Table 77. Sanofi Company Information
Table 78. Sanofi Introduction and Business Overview
Table 79. Sanofi Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Sanofi Oncology Adjuvants Product Offerings
Table 81. Sanofi Recent Development
Table 82. AstraZeneca Company Information
Table 83. AstraZeneca Introduction and Business Overview
Table 84. AstraZeneca Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. AstraZeneca Oncology Adjuvants Product Offerings
Table 86. AstraZeneca Recent Development
Table 87. Pfizer Company Information
Table 88. Pfizer Introduction and Business Overview
Table 89. Pfizer Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Pfizer Oncology Adjuvants Product Offerings
Table 91. Pfizer Recent Development
Table 92. Hengrui Medicine Company Information
Table 93. Hengrui Medicine Introduction and Business Overview
Table 94. Hengrui Medicine Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Hengrui Medicine Oncology Adjuvants Product Offerings
Table 96. Hengrui Medicine Recent Development
Table 97. Hisun Pharmaceutical Company Information
Table 98. Hisun Pharmaceutical Introduction and Business Overview
Table 99. Hisun Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Hisun Pharmaceutical Oncology Adjuvants Product Offerings
Table 101. Hisun Pharmaceutical Recent Development
Table 102. Yibai Pharmaceutical Company Information
Table 103. Yibai Pharmaceutical Introduction and Business Overview
Table 104. Yibai Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Yibai Pharmaceutical Oncology Adjuvants Product Offerings
Table 106. Yibai Pharmaceutical Recent Development
Table 107. SL Pharmaceutical Company Information
Table 108. SL Pharmaceutical Introduction and Business Overview
Table 109. SL Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. SL Pharmaceutical Oncology Adjuvants Product Offerings
Table 111. SL Pharmaceutical Recent Development
Table 112. Zhendong Pharmaceutical Company Information
Table 113. Zhendong Pharmaceutical Introduction and Business Overview
Table 114. Zhendong Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Zhendong Pharmaceutical Oncology Adjuvants Product Offerings
Table 116. Zhendong Pharmaceutical Recent Development
Table 117. Main Luck Pharmaceuticals Company Information
Table 118. Main Luck Pharmaceuticals Introduction and Business Overview
Table 119. Main Luck Pharmaceuticals Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Main Luck Pharmaceuticals Oncology Adjuvants Product Offerings
Table 121. Main Luck Pharmaceuticals Recent Development
Table 122. Sanjiu Medical Company Information
Table 123. Sanjiu Medical Introduction and Business Overview
Table 124. Sanjiu Medical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Sanjiu Medical Oncology Adjuvants Product Offerings
Table 126. Sanjiu Medical Recent Development
Table 127. Livzon Pharmaceutical Company Information
Table 128. Livzon Pharmaceutical Introduction and Business Overview
Table 129. Livzon Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Livzon Pharmaceutical Oncology Adjuvants Product Offerings
Table 131. Livzon Pharmaceutical Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Oncology Adjuvants Downstream Customers
Table 135. Oncology Adjuvants Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology Adjuvants Product Picture
Figure 2. Global Oncology Adjuvants Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Oncology Adjuvants Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Oncology Adjuvants Sales Volume (2019-2030) & (K Units)
Figure 5. Global Oncology Adjuvants Sales Price (2019-2030) & (US$/Unit)
Figure 6. Oncology Adjuvants Report Years Considered
Figure 7. Global Oncology Adjuvants Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Oncology Adjuvants Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology Adjuvants Revenue in 2023
Figure 10. Oncology Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Radiotherapy Picture
Figure 12. Chemotherapy Picture
Figure 13. Immunotherapy Picture
Figure 14. Hormone therapy Picture
Figure 15. Targeted therapy Picture
Figure 16. Global Oncology Adjuvants Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Oncology Adjuvants Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Oncology Adjuvants Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 19. Global Oncology Adjuvants Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Oncology Adjuvants Price by Type (2019-2030) & (US$/Unit)
Figure 21. Product Picture of Cancer Research Institutes
Figure 22. Product Picture of Cancer Hospitals
Figure 23. Global Oncology Adjuvants Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Oncology Adjuvants Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Oncology Adjuvants Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global Oncology Adjuvants Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Oncology Adjuvants Price by Application (2019-2030) & (US$/Unit)
Figure 28. North America Oncology Adjuvants Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Oncology Adjuvants Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Oncology Adjuvants Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Oncology Adjuvants Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Oncology Adjuvants Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Oncology Adjuvants Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Oncology Adjuvants Sales Volume (%), (2019-2030)
Figure 40. United States Oncology Adjuvants Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Oncology Adjuvants Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Oncology Adjuvants Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Oncology Adjuvants Sales Value by Application (%), 2023 VS 2030
Figure 46. China Oncology Adjuvants Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
Figure 48. China Oncology Adjuvants Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Oncology Adjuvants Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Oncology Adjuvants Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Oncology Adjuvants Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Oncology Adjuvants Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Oncology Adjuvants Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Oncology Adjuvants Sales Value by Application (%), 2023 VS 2030
Figure 58. India Oncology Adjuvants Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
Figure 60. India Oncology Adjuvants Sales Value by Application (%), 2023 VS 2030
Figure 61. Oncology Adjuvants Industrial Chain
Figure 62. Oncology Adjuvants Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Oncology Adjuvants Market Trends
Table 2. Oncology Adjuvants Market Drivers & Opportunity
Table 3. Oncology Adjuvants Market Challenges
Table 4. Oncology Adjuvants Market Restraints
Table 5. Global Oncology Adjuvants Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Oncology Adjuvants Revenue Market Share by Company (2019-2024)
Table 7. Global Oncology Adjuvants Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Oncology Adjuvants Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Oncology Adjuvants Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Oncology Adjuvants Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Oncology Adjuvants Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Oncology Adjuvants
Table 13. Global Oncology Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Adjuvants as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Oncology Adjuvants Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Oncology Adjuvants Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Oncology Adjuvants Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Oncology Adjuvants Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Oncology Adjuvants Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Oncology Adjuvants Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Oncology Adjuvants Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Oncology Adjuvants Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Oncology Adjuvants Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Oncology Adjuvants Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Oncology Adjuvants Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Oncology Adjuvants Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Oncology Adjuvants Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Oncology Adjuvants Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Oncology Adjuvants Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Oncology Adjuvants Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Oncology Adjuvants Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Oncology Adjuvants Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Oncology Adjuvants Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Oncology Adjuvants Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Oncology Adjuvants Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Oncology Adjuvants Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Oncology Adjuvants Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Oncology Adjuvants Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Oncology Adjuvants Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Oncology Adjuvants Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Oncology Adjuvants Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Oncology Adjuvants Sales Value by Region (2019-2024) & (%)
Table 44. Global Oncology Adjuvants Sales Value by Region (2025-2030) & (%)
Table 45. Global Oncology Adjuvants Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Oncology Adjuvants Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Oncology Adjuvants Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Oncology Adjuvants Sales Volume by Region (2019-2024) & (%)
Table 49. Global Oncology Adjuvants Sales Volume by Region (2025-2030) & (%)
Table 50. Global Oncology Adjuvants Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Oncology Adjuvants Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Oncology Adjuvants Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Oncology Adjuvants Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Oncology Adjuvants Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Oncology Adjuvants Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Oncology Adjuvants Sales Volume, (2025-2030) & (K Units)
Table 57. Eli Lilly Company Information
Table 58. Eli Lilly Introduction and Business Overview
Table 59. Eli Lilly Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Eli Lilly Oncology Adjuvants Product Offerings
Table 61. Eli Lilly Recent Development
Table 62. Amgen Company Information
Table 63. Amgen Introduction and Business Overview
Table 64. Amgen Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Amgen Oncology Adjuvants Product Offerings
Table 66. Amgen Recent Development
Table 67. BMS Company Information
Table 68. BMS Introduction and Business Overview
Table 69. BMS Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. BMS Oncology Adjuvants Product Offerings
Table 71. BMS Recent Development
Table 72. Biogen Company Information
Table 73. Biogen Introduction and Business Overview
Table 74. Biogen Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Biogen Oncology Adjuvants Product Offerings
Table 76. Biogen Recent Development
Table 77. Sanofi Company Information
Table 78. Sanofi Introduction and Business Overview
Table 79. Sanofi Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Sanofi Oncology Adjuvants Product Offerings
Table 81. Sanofi Recent Development
Table 82. AstraZeneca Company Information
Table 83. AstraZeneca Introduction and Business Overview
Table 84. AstraZeneca Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. AstraZeneca Oncology Adjuvants Product Offerings
Table 86. AstraZeneca Recent Development
Table 87. Pfizer Company Information
Table 88. Pfizer Introduction and Business Overview
Table 89. Pfizer Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Pfizer Oncology Adjuvants Product Offerings
Table 91. Pfizer Recent Development
Table 92. Hengrui Medicine Company Information
Table 93. Hengrui Medicine Introduction and Business Overview
Table 94. Hengrui Medicine Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Hengrui Medicine Oncology Adjuvants Product Offerings
Table 96. Hengrui Medicine Recent Development
Table 97. Hisun Pharmaceutical Company Information
Table 98. Hisun Pharmaceutical Introduction and Business Overview
Table 99. Hisun Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Hisun Pharmaceutical Oncology Adjuvants Product Offerings
Table 101. Hisun Pharmaceutical Recent Development
Table 102. Yibai Pharmaceutical Company Information
Table 103. Yibai Pharmaceutical Introduction and Business Overview
Table 104. Yibai Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Yibai Pharmaceutical Oncology Adjuvants Product Offerings
Table 106. Yibai Pharmaceutical Recent Development
Table 107. SL Pharmaceutical Company Information
Table 108. SL Pharmaceutical Introduction and Business Overview
Table 109. SL Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. SL Pharmaceutical Oncology Adjuvants Product Offerings
Table 111. SL Pharmaceutical Recent Development
Table 112. Zhendong Pharmaceutical Company Information
Table 113. Zhendong Pharmaceutical Introduction and Business Overview
Table 114. Zhendong Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Zhendong Pharmaceutical Oncology Adjuvants Product Offerings
Table 116. Zhendong Pharmaceutical Recent Development
Table 117. Main Luck Pharmaceuticals Company Information
Table 118. Main Luck Pharmaceuticals Introduction and Business Overview
Table 119. Main Luck Pharmaceuticals Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Main Luck Pharmaceuticals Oncology Adjuvants Product Offerings
Table 121. Main Luck Pharmaceuticals Recent Development
Table 122. Sanjiu Medical Company Information
Table 123. Sanjiu Medical Introduction and Business Overview
Table 124. Sanjiu Medical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Sanjiu Medical Oncology Adjuvants Product Offerings
Table 126. Sanjiu Medical Recent Development
Table 127. Livzon Pharmaceutical Company Information
Table 128. Livzon Pharmaceutical Introduction and Business Overview
Table 129. Livzon Pharmaceutical Oncology Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Livzon Pharmaceutical Oncology Adjuvants Product Offerings
Table 131. Livzon Pharmaceutical Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Oncology Adjuvants Downstream Customers
Table 135. Oncology Adjuvants Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology Adjuvants Product Picture
Figure 2. Global Oncology Adjuvants Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Oncology Adjuvants Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Oncology Adjuvants Sales Volume (2019-2030) & (K Units)
Figure 5. Global Oncology Adjuvants Sales Price (2019-2030) & (US$/Unit)
Figure 6. Oncology Adjuvants Report Years Considered
Figure 7. Global Oncology Adjuvants Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Oncology Adjuvants Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology Adjuvants Revenue in 2023
Figure 10. Oncology Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Radiotherapy Picture
Figure 12. Chemotherapy Picture
Figure 13. Immunotherapy Picture
Figure 14. Hormone therapy Picture
Figure 15. Targeted therapy Picture
Figure 16. Global Oncology Adjuvants Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Oncology Adjuvants Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Oncology Adjuvants Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 19. Global Oncology Adjuvants Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Oncology Adjuvants Price by Type (2019-2030) & (US$/Unit)
Figure 21. Product Picture of Cancer Research Institutes
Figure 22. Product Picture of Cancer Hospitals
Figure 23. Global Oncology Adjuvants Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Oncology Adjuvants Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Oncology Adjuvants Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global Oncology Adjuvants Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Oncology Adjuvants Price by Application (2019-2030) & (US$/Unit)
Figure 28. North America Oncology Adjuvants Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Oncology Adjuvants Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Oncology Adjuvants Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Oncology Adjuvants Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Oncology Adjuvants Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Oncology Adjuvants Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Oncology Adjuvants Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Oncology Adjuvants Sales Volume (%), (2019-2030)
Figure 40. United States Oncology Adjuvants Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Oncology Adjuvants Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Oncology Adjuvants Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Oncology Adjuvants Sales Value by Application (%), 2023 VS 2030
Figure 46. China Oncology Adjuvants Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
Figure 48. China Oncology Adjuvants Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Oncology Adjuvants Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Oncology Adjuvants Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Oncology Adjuvants Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Oncology Adjuvants Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Oncology Adjuvants Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Oncology Adjuvants Sales Value by Application (%), 2023 VS 2030
Figure 58. India Oncology Adjuvants Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Oncology Adjuvants Sales Value by Type (%), 2023 VS 2030
Figure 60. India Oncology Adjuvants Sales Value by Application (%), 2023 VS 2030
Figure 61. Oncology Adjuvants Industrial Chain
Figure 62. Oncology Adjuvants Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232